Dilate coronary arteries, increase coronary blood flow, and improve myocardial hypoxia; improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; inhibit platelet aggregation, reduce blood viscosity, and lower blood lipids.

Dilate coronary arteries, increase coronary blood flow, and improve myocardial hypoxia; inhibit platelet aggregation, inhibit platelet release reaction, reduce blood viscosity, and lower blood lipids.

Compound Danshen Tablets have the effects of dilating coronary arteries, increasing coronary blood flow, slowing heart rate, and improving myocardial hypoxia; it can improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; it can inhibit platelet aggregation, inhibit platelet release reaction, reduce blood viscosity, and lower blood lipids.

It is a diuretic, diuretic, and jaundice-relieving drug.

Clears away heat and dampness, promotes dampness and relieves jaundice, and is a ministerial drug

Clears away heat and dampness, promotes dampness and relieves jaundice, and is a ministerial drug

It has laxative effect and is a ministerial drug.

It has laxative effect and is a ministerial drug.

Soothes the liver and gallbladder, promotes qi and relieves pain, and is also an adjuvant

Soothes the liver and gallbladder, promotes qi and relieves pain, and is also an adjuvant

Soothes the liver and gallbladder, promotes qi and relieves pain, and is also an adjuvant

Soothes the liver and gallbladder, promotes qi and relieves pain, and is also an adjuvant

It is also an assistant to promote qi and diuresis

This product is a fluoroquinolone antibacterial drug with a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria. It has good antibacterial activity against the following bacteria in vitro: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes and other Enterobacter species, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. Norfloxacin also has antibacterial activity against multi-drug resistant bacteria in vitro. It also has good antibacterial effects on penicillin-resistant Neisseria gonorrhoeae, Haemophilus influenzae and Moraxella catarrhalis. Norfloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.